Related references
Note: Only part of the references are listed.From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J. A. Punt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer
A. Blomme et al.
ONCOGENE (2017)
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
Zoltan Lohinai et al.
SCIENTIFIC REPORTS (2017)
Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing
Andrew L. Paek et al.
CELL (2016)
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
Zoran Gatalica et al.
FAMILIAL CANCER (2016)
Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model
Yang Wang et al.
JOURNAL OF PROTEOMICS (2016)
Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma
Evelyne Louis et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Exosomat Proteins as Diagnostic Biomarkers in Lung Cancer
Birgitte Sandfeld-Paulsen et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival
Friedrich-Carl von Rundstedt et al.
JOURNAL OF UROLOGY (2016)
Exosomal proteins as prognostic biomarkers in non-small cell lung cancer
B. Sandfeld-Paulsen et al.
MOLECULAR ONCOLOGY (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
Translating RNA sequencing into clinical diagnostics: opportunities and challenges
Sara A. Byron et al.
NATURE REVIEWS GENETICS (2016)
Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
Mauro Corrado et al.
ONCOTARGET (2016)
Genome-wide epigenomic profiling for biomarker discovery
Rene A. M. Dirks et al.
CLINICAL EPIGENETICS (2016)
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai et al.
JOURNAL OF CANCER (2016)
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
Ran Zhao et al.
EBIOMEDICINE (2016)
Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients
Meng Zhou et al.
SCIENTIFIC REPORTS (2016)
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
Pascale Tomasini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Patterns of ribosomal protein expression specify normal and malignant human cells
Joao C. Guimaraes et al.
GENOME BIOLOGY (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
Proteomic Challenges: Sample Preparation Techniques for Microgram-Quantity Protein Analysis from Biological Samples
Peter Feist et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer
Pamela Maris et al.
PLOS MEDICINE (2015)
Metabolomics for Biomarker Discovery: Moving to the Clinic
Aihua Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group
Brian D. Kelly et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Cytotoxic and DNA-Targeted Therapy in Urothelial Cancer
Arjun V. Balar et al.
CANCER (2015)
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer
Elzbieta Szmida et al.
JOURNAL OF APPLIED GENETICS (2015)
An update on PARP inhibitors-moving to the adjuvant setting
Amir Sonnenblick et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Karen Lise Garm Spindler et al.
PLOS ONE (2015)
Metabolic signatures of human breast cancer
Prachi Mishra et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
Circulating DNA as biomarker in breast cancer
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH (2015)
Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease
Yingchang Zou et al.
CANCER BIOMARKERS (2014)
Humanized NOD-SCID IL2rg-/- mice as a preclinical model for cancer research and its potential use for individualized cancer therapies
Qianjun Zhou et al.
CANCER LETTERS (2014)
Assessment, origin, and implementation of breath volatile cancer markers
Hossam Haick et al.
CHEMICAL SOCIETY REVIEWS (2014)
The genomic landscape of retinoblastoma: a review
Brigitte L. Theriault et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
MicroRNAs (miRNAs) as Biomarker(s) for Prognosis and Diagnosis of Gastrointestinal (GI) Cancers
Muzafar A. Macha et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Genomics of alternative splicing: evolution, development and pathophysiology
Eric R. Gamazon et al.
HUMAN GENETICS (2014)
Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer
Karen-Lise Garm Spindler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
Xuelian Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays
Carol E. Parker et al.
MOLECULAR ONCOLOGY (2014)
Exhaled Breath Analysis for Lung Cancer Detection Using Ion Mobility Spectrometry
Hiroshi Handa et al.
PLOS ONE (2014)
Chemical proteomic strategies for the discovery and development of anticancer drugs
Yuanzhen Liu et al.
PROTEOMICS (2014)
PITFALLS AND LIMITATIONS IN TRANSLATION FROM BIOMARKER DISCOVERY TO CLINICAL UTILITY IN PREDICTIVE AND PERSONALISED MEDICINE
Elisabeth Drucker et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
Animal models in translational medicine: Validation and prediction
Tinneke Denayer et al.
NEW HORIZONS IN TRANSLATIONAL MEDICINE (2014)
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine
Crispin Hiley et al.
GENOME BIOLOGY (2014)
Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
Qi Chen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Interstitial fluid-A reflection of the tumor cell microenvironment and secretome
Hanne Haslene-Hox et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Biomarker Discovery for Heterogeneous Diseases
Garrick Wallstrom et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
Despina Siolas et al.
CANCER RESEARCH (2013)
Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications
Meike de Wit et al.
CLINICAL BIOCHEMISTRY (2013)
Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome-Wide Profiling and Validation Study
Maria Dolores Giraldez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Toward a comprehensive and systematic methylome signature in colorectal cancers
Hassan Ashktorab et al.
EPIGENETICS (2013)
Chemotherapy of MMR-deficient colorectal cancer
N. Devaud et al.
FAMILIAL CANCER (2013)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
Hui K. Gan et al.
FEBS JOURNAL (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma
Liu Ouyang et al.
MEDICAL ONCOLOGY (2013)
Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
Guang-Hui Liu et al.
TUMOR BIOLOGY (2013)
Deciphering Signatures of Mutational Processes Operative in Human Cancer
Ludmil B. Alexandrov et al.
CELL REPORTS (2013)
Comparative marker analysis of extracellular vesicles in different human cancer types
Yusuke Yoshioka et al.
JOURNAL OF EXTRACELLULAR VESICLES (2013)
Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
Elisabeth Drucker et al.
EPMA JOURNAL (2013)
The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines
Yishan Wang et al.
CANCER BIOMARKERS (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Proximal Fluid Proteome Profiling of Mouse Colon Tumors Reveals Biomarkers for Early Diagnosis of Human Colorectal Cancer
Remond J. A. Fijneman et al.
CLINICAL CANCER RESEARCH (2012)
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS
M. D. Vincent et al.
CURRENT ONCOLOGY (2012)
Chemistry-based functional proteomics for drug target deconvolution
Kui Wang et al.
EXPERT REVIEW OF PROTEOMICS (2012)
Characterization of Breast Cancer Interstitial Fluids by TmT Labeling, LTQ-Orbitrap Velos Mass Spectrometry, and Pathway Analysis
Cinzia Raso et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Protein Expression Signatures for Inhibition of Epidermal Growth Factor Receptor-mediated Signaling
Matthew V. Myers et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet et al.
LUNG CANCER (2012)
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
John R. Prensner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Chemical proteomics: terra incognita for novel drug target profiling
Fuqiang Huang et al.
CHINESE JOURNAL OF CANCER (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies
Andrei Turtoi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Jorja D. Warren et al.
BMC MEDICINE (2011)
MicroRNA Signatures: Novel Biomarker for Colorectal Cancer?
Xiaoya Luo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis
Jean-Nicolas Cornu et al.
EUROPEAN UROLOGY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Differential Proteomic Analysis of Renal Cell Carcinoma Tissue Interstitial Fluid
Pang-ning Teng et al.
JOURNAL OF PROTEOME RESEARCH (2011)
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Phillip G. Febbo et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation
Ebony R. Hoskins et al.
PLOS ONE (2011)
Immuno-PCR: a promising ultrasensitive diagnostic method to detect antigens and antibodies
Nada Malou et al.
TRENDS IN MICROBIOLOGY (2011)
Human SP-A1 (SFTPA1) variant-specific 3′ UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene
Patricia Silveyra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Combinatorial biomarker expression in breast cancer
Emad A. Rakha et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The Screening of Volatile Markers for Hepatocellular Carcinoma
Tao Qin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T. Weigel et al.
ENDOCRINE-RELATED CANCER (2010)
A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue
Vladimir Tolmachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Breath gas aldehydes as biomarkers of lung cancer
Patricia Fuchs et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Biomarkers for Colorectal Cancer
Takuji Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Characterization of the Liver Tissue Interstitial Fluid (TIF) Proteome Indicates Potential for Application in Liver Disease Biomarker Discovery
Wei Sun et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Up-regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
Pavel Gromov et al.
MOLECULAR ONCOLOGY (2010)
Quantitative breath analysis of volatile organic compounds of lung cancer patients
Geng Song et al.
LUNG CANCER (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)
Lenny Dang et al.
NATURE (2010)
DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples
Tim Fugmann et al.
PROTEOMICS (2010)
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Guilherme Rabinowits et al.
CLINICAL LUNG CANCER (2009)
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study
Miriam Koopman et al.
EUROPEAN JOURNAL OF CANCER (2009)
Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
Gaetan Des Guetz et al.
EUROPEAN JOURNAL OF CANCER (2009)
On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
Anna Orlova et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Target profiling of small molecules by chemical proteomics
Uwe Rix et al.
NATURE CHEMICAL BIOLOGY (2009)
STRING 8-a global view on proteins and their functional interactions in 630 organisms
Lars J. Jensen et al.
NUCLEIC ACIDS RESEARCH (2009)
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Mariantonia Logozzi et al.
PLOS ONE (2009)
Tissue microarrays: emerging standard for biomarker validation
Saima Hassan et al.
CURRENT OPINION IN BIOTECHNOLOGY (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
Robert L. Camp et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A mouse model repository for cancer biomarker discovery
Karen S. Kelly-Spratt et al.
JOURNAL OF PROTEOME RESEARCH (2008)
In Vivo Tumor Secretion Probing Via Ultrafiltration and Tissue Chamber:Implication for Anti-Cancer Drugs Targeting Secretome
Chun-Ming Huang et al.
Recent Patents on Anti-Cancer Drug Discovery (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies
Philippe Kischel et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Zdenko Herceg et al.
MOLECULAR ONCOLOGY (2007)
Solid-phase extraction of N-linked glycopeptides
Yuan Tian et al.
NATURE PROTOCOLS (2007)
Alternative splicing: an emerging topic in molecular and clinical oncology
Maria J. Pajares et al.
LANCET ONCOLOGY (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Mass spectrometric proteomics profiles of in vivo tumor secretomes:: Capillary ultrafiltration sampling of regressive tumor masses
Chun-Ming Huang et al.
PROTEOMICS (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Protein Equalizer™ Technology:: The quest for a democratic proteome
Pier Giorgio Righetti et al.
PROTEOMICS (2006)
Fibronectin as target for tumor therapy
M Kaspar et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The colorectal microRNAome
JM Cummins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature
Christoph Roesli et al.
NATURE PROTOCOLS (2006)
Laser-capture microdissection
Virginia Espina et al.
NATURE PROTOCOLS (2006)
Guidelines for the next 10 years of proteomics
MR Wilkins et al.
PROTEOMICS (2006)
A method for high-throughput gene expression signature analysis
David Peck et al.
GENOME BIOLOGY (2006)
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig et al.
NATURE REVIEWS CANCER (2005)
Two-stage designs for experiments with a large number of hypotheses
S Zehetmayer et al.
BIOINFORMATICS (2005)
Microdialysis -: An in vivo technique for studies of growth factors in breast cancer
C Dabrosin
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature
JN Rybak et al.
NATURE METHODS (2005)
A simple inexpensive method for the production of tissue microarrays from needle biopsy specimens - Examples with prostate cancer
MW Datta et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry
H Baker et al.
ORAL ONCOLOGY (2005)
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment -: A novel resource for biomarker and therapeutic target discovery
JE Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA)
NL Anderson et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Olfactory detection of human bladder cancer by dogs: proof of principle study
CM Willis et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
P Oh et al.
NATURE (2004)
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry
H Zhang et al.
NATURE BIOTECHNOLOGY (2003)
Lab-on-a-chip for drug development
BH Weigl et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Biology of prostate-specific antigen
SP Balk et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Isolation of interstitial fluid from rat mammary tumors by a centrifugation method
H Wiig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Chemical strategies for functional proteomics
GC Adam et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Protein expression signatures: an application of proteomics
BP Bradley et al.
MARINE ENVIRONMENTAL RESEARCH (2002)
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma
C Jerónimo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins
MS Fejzo et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
A systematic overview of chemotherapy effects in colorectal cancer
P Ragnhammar et al.
ACTA ONCOLOGICA (2001)
In silico cloning of novel endothelial-specific genes
L Huminiecki et al.
GENOME RESEARCH (2000)
Genome changes and gene expression in human solid tumors
JW Gray et al.
CARCINOGENESIS (2000)
Share Paper
